高流量人工呼吸器の世界市場(2023-2028)

◆英語タイトル:High Flow Ventilators Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)

Mordor Intelligenceが発行した調査報告書(MOR23MAC013)◆商品コード:MOR23MAC013
◆発行会社(リサーチ会社):Mordor Intelligence
◆発行日:2023年1月23日
◆ページ数:120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,750 ⇒換算¥693,500見積依頼/購入/質問フォーム
Corporate License(複数拠点内で共有可)USD8,750 ⇒換算¥1,277,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Mordor Intelligence社の市場調査書によると、年度末に1,707.3百万ドルであった世界の高流量人工呼吸器市場規模が、予測期間中、CAGR 6.2%で拡大し、2,398.3百万ドルへ上ると推測されています。本調査書では、高流量人工呼吸器の世界市場について調査・分析を行い、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、モダリティ別(移動型、台車搭載型)分析、エンドユーザー別(病院、外来手術センター、その他)分析、地域別(アメリカ、カナダ、メキシコ、ドイツ、イギリス、フランス、イタリア、スペイン、中国、日本、インド、オーストラリア、韓国、中東、南アフリカ、ブラジル、アルゼンチン)分析、競争状況、市場機会・将来動向など、以下の構成でお届けします。また、市場調査の対象企業には、Getinge AB、Hamilton Medical、HERSILL、Koninklijke Philips NV、Medtronic PLC、Movair、VYAIRE、Asahi Kasei (ZOLL Medical Corporation)などが含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界の高流量人工呼吸器市場規模:モダリティ別
- 移動型高流量人工呼吸器の市場規模
- 台車搭載型高流量人工呼吸器の市場規模
・世界の高流量人工呼吸器市場規模:エンドユーザー別
- 病院における市場規模
- 外来手術センターにおける市場規模
- その他エンドユーザーにおける市場規模
・世界の高流量人工呼吸器市場規模:地域別
- 北米の高流量人工呼吸器市場規模
アメリカの高流量人工呼吸器市場規模
カナダの高流量人工呼吸器市場規模
メキシコの高流量人工呼吸器市場規模

- ヨーロッパの高流量人工呼吸器市場規模
ドイツの高流量人工呼吸器市場規模
イギリスの高流量人工呼吸器市場規模
フランスの高流量人工呼吸器市場規模

- アジア太平洋の高流量人工呼吸器市場規模
中国の高流量人工呼吸器市場規模
日本の高流量人工呼吸器市場規模
インドの高流量人工呼吸器市場規模

- 南米/中東の高流量人工呼吸器市場規模
ブラジルの高流量人工呼吸器市場規模
アルゼンチンの高流量人工呼吸器市場規模
サウジアラビアの高流量人工呼吸器市場規模
・競争状況
・市場機会・将来動向

The high-flow ventilators market was valued at USD 1,707.3 million in the base year, and it is expected to reach USD 2,398.3 million by the end of the forecast period, registering a CAGR of 6.2%

The emergence of the COVID-19 pandemic had an adverse effect on the world economy and the healthcare system. The lockdown all over the globe affected the supply chain of pharmaceuticals, medical devices, and biotechnological products. The severe impact of the SARS-CoV-2 virus on people with existing respiratory diseases/disorders further increased the risk for the target population. For instance, as per the research study published in the National Libray of Medicine in April 2021, the risk of severe COVID-19 in people with asthma was relatively small but people with Chronic obstructive pulmonary disease (COPD) and interstitial lung disease appeared to have a modestly increased risk of severe disease due to COVID-19. This was expected to increase the market growth for high-flow ventilators. Therefore, the above-mentioned stated that the high flow ventilators market grew significantly around the world with the emergence of the COVID-19 pandemic, but it would see a downward growth with the decreasing cases of COVID-19 globally, and slowly the market would show steady growth in certain geographies even after the reduction in the impact of the COVID-19 due to other respiratory diseases.

The prevalence and incidence of respiratory illness is rising currently and the global prevalence of the diseases is expected to grow in posterity. People who work in drug manufacturing, and antibiotics manufacturing factories complain about breathing issues and work-related asthma is becoming more prevalent among this target population. For instance, according to the study published in the Lung India in December 2021, COPD is estimated to be 7.4% prevalent in India. COPD was found to be prevalent in 11 percent of urban areas and 5.6 percent of rural areas. Moreover, as per the study published in Allergology International in January 2022, Asthma is a chronic inflammatory disease of the lungs that causes airway constriction and hyperresponsiveness, as well as wheezing and coughing. Approximately 1,177,000 people in Japan are being treated for asthma. Hence, owing to the high prevalence of respiratory diseases, the demand for high-flow ventilators is expected to increase which is expected to boost the growth of the studied market.

Moreover, the article published in Jama Network in November 2021 stated that chronic lower respiratory disease (CLRD) is the fourth leading cause of death in the United States, and approximately 14.8 million people have been diagnosed with chronic obstructive pulmonary disease (COPD) and more than 25 million people have asthma recently. Therefore, the growing prevalence of respiratory diseases is driving the demand for high-flow ventilators used for providing oxygen therapy to patients and overcoming breathing issues. Thereby, driving the growth of the studied market.

Technological advancement in the ventilators product by the market players is expected to boost the market over the forecast period.For instance, in October 2021, Movair, a respiratory therapy company launched Luisa, an advanced ventilator intended for use in homes, institutions, hospitals or portable applications for both invasive and non-invasive ventilation.

However, respiratory diseases have a high impact on the economy, and this may hamper the global demand for high-flow ventilators in the studied period.

High Flow Ventilators Market Trends

The Portable High Flow Ventilators Segment is Expected to Hold Significant Share in the Market Over the Forecast Period

The portable high-flow ventilators segment is expected to hold a significant share in the studied market through the forecast period. This can be attributed to the rising adoption of these ventilators, due to integrated gaussmeter, superior monitoring capabilities, and advanced modes. The transport of patients within a hospital setting is a common event that exposes patients to risks normally not encountered in a stationary environment. Moreover, portable high-flow ventilators transform ventilatory care through their small size, portability, ease of use, versatility, and extended battery life. By costing as little as a third of other ICU ventilators and offering both invasive and noninvasive capabilities, they are ideally suited, no matter what their location or severity. These factors are expected to impel the segment’s development in the forecasted period.

The studies demonstrating the benefits of the usage of portable high-flow ventilators in different disease conditions are also boosting the growth of the market. For instance, a Karger Journal article published in December 2021 reported that High-flow Nasal Oxygen (HFNO) improves exercise capacity, oxygen saturation, and symptoms in patients with chronic obstructive pulmonary disease (COPD). It also concluded that in patients with Chronic obstructive pulmonary disease, there is severe exercise limitation, and HFNO delivered by a battery-supplied portable device was more effective in improving walking distance than usual oxygen supplementation. Such studies suggest the usage of portable high-flow ventilators is beneficial in reducing symptoms and daily activities and thus expected to drive the segment’s growth in the given timeframe.

The launch of products by the market players is also propelling the growth of the segment. For instance, in October 2021, Movairlaunched Luisa in the United States. It is an advanced ventilator intended for use in homes, institutions, hospitals, or portable applications for both invasive and non-invasive ventilation. Luisa is a portable and compact home ventilator now available in the United States and one of the first with the added benefit of high-flow oxygen therapy. Such launches are propelling the growth of the segment.

Thus, owing to the abovementioned factors, the portable high-flow ventilators segment is expected to show growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America accounted for a significant market share, and it is estimated to maintain its dominance over the forecast period. The United States is a hub for technological advancements and has a well-established healthcare infrastructure. The key factors driving the market are the increasing geriatric population and the growing number of respiratory diseases in the country. For instance, according to the Asthma and Allergy Foundation of America (AAFA), in April 2022, roughly 1 in 13 Americans had asthma, which is about 25 million people. As per the same source, about 5.1 million American children have asthma under the age of 18. The Asthma and Allergy Foundation of America (AAFA) stated that asthma is more common in female adults than in male adults. Around 9.8% of female adults have asthma, compared to 6.1% of male adults. Thus, patients with respiratory illness often require high-flow ventilators for treatment purposes, creating opportunities for the ventilators, and thereby boosting the market growth.

Furthermore, the increasing adoption of various business strategies by the market players such as collaborations, partnerships, and product launches in the region is also contributing to the market expansion. For instance, in August 2021, Max Ventilator reported the launch of the High Flow oxygen Therapy (HFOT) device and WeanX in its new ventilator range category. The HFOT device gives nearly 100 percent chances of survival with less operating costs than a traditional ventilator, adding force and strength to the ongoing battle against a resurgent COVID-19 virus. Thus, the aforementioned factors are expected to drive market growth in the region during the forecast period.

High Flow Ventilators Market Competitor Analysis

The studied market is fragmented and moderately competitive. Some of the key players in the market include companies, such as Getinge AB, Hamilton Medical, HERSILL, Koninklijke Philips NV, Medtronic, ResMed, VYAIRE, and Asahi Kasei (ZOLL Medical Corporation). These companies are actively involved in product innovations and technological advancements to sustain their positions in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
❖ レポートの目次 ❖

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Prevalence of Respiratory Diseases
4.2.2 Increasing Adoption of High-end Technologies in Critical Care
4.2.3 Increasing Geriatric Population
4.3 Market Restraints
4.3.1 Economic Impact of Respiratory Disorders
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value – USD Million)
5.1 By Modality
5.1.1 Portable High Flow Ventilators
5.1.2 Trolley Mounted High Flow Ventilators
5.2 By End User
5.2.1 Hospitals
5.2.2 Ambulatory Surgical Centers
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Getinge AB
6.1.2 Hamilton Medical
6.1.3 HERSILL
6.1.4 Koninklijke Philips NV
6.1.5 Medtronic PLC
6.1.6 Movair
6.1.7 VYAIRE
6.1.8 Asahi Kasei (ZOLL Medical Corporation)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 高流量人工呼吸器の世界市場(2023-2028)(High Flow Ventilators Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028))]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆